Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-thioguanine (Thiosix) registry in inflammatory bowel disease
NL-OMON28619Active, not recruiting
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tioguanine in inflammatory bowel disease (IBD), Crohn's disease and autoimmune colitis, sponsored by None. Primary endpoint: Incidence of nodular regenerative hyperplasia. Started Jul 2015; status: active, not recruiting.
02
Drugs
tioguanine
03
Conditions
inflammatory bowel disease (IBD)Crohn's diseaseautoimmune colitis
Beyond the preview
Go deeper on NL-OMON28619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28619.